Cytochrome P450 enzymes selectively oxidize relatively unactivated sites in a range of model drug-like substrates in vitro. The hydroxylated products can be transformed into selectively fluorinated systems, providing a rapid sequential method for the identification, activation and fluorination of saturated sites in drug candidates.
This is a preview of subscription content, log in via an institution to check access.
Kim Caesar
References
Chambers, R.D. Fluorine in Organic Chemistry (Blackwell, Oxford, 2004).
Gouverneur, V. et al. Chem. Soc. Rev. 37, 320–330 (2008).
Müller, K. et al. Science 317, 1881–1886 (2007).
Sandford, G. Houben-Weyl Methods of Molecular Transformations Vol. 34 (ed. Percy, J.M.) 21–38 (Thieme, Stuttgart, Germany, 2006).
Rentmeister, A., Arnold, F.H. & Fasan, R. Nat. Chem. Biol. 5, 26–28 (2009).
Lohmann, W. & Karst, U. Anal. Bioanal. Chem. 391, 79–96 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sandford, G. Engineering fluorination. Nat Chem Biol 5, 6–7 (2009). https://doi.org/10.1038/nchembio0109-6
Issue Date:
DOI: https://doi.org/10.1038/nchembio0109-6
- Springer Nature America, Inc.